Global Cancer Cachexia Market
Cancer Cachexia Market Forecasted to Reach $3.14 Billion by 2028 with a CAGR of 6.2% - Long-term Forecast to 2033
August 23, 2024 11:51 ET | Research and Markets
Dublin, Aug. 23, 2024 (GLOBE NEWSWIRE) -- The "Global Cancer Cachexia Market Report 2024" report has been added to ResearchAndMarkets.com's offering. Global cancer cachexia market is forecast to...
cmi_logo.png
[Latest] Global Cancer Cachexia Market Size/Share Worth USD 5.1 Billion by 2033 at a 5.1% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth, Growth Rate, Value)
May 03, 2024 04:30 ET | Custom Market Insights
Austin, TX, USA, May 03, 2024 (GLOBE NEWSWIRE) -- Custom Market Insights has published a new research report titled “Cancer Cachexia Market Size, Trends and Insights By Therapeutics (Progestogen,...
Global Clinical Nutrition For Cancer Care Market
Global Clinical Nutrition For Cancer Care Report 2024-2030, by Product (Oral, Nutrition Enteral Feeding Formulas, Parenteral Nutrition), Stage, Sales Channel, Region and Segment Forecasts
April 11, 2024 04:23 ET | Research and Markets
Dublin, April 11, 2024 (GLOBE NEWSWIRE) -- The "Global Clinical Nutrition For Cancer Care Market Size, Share & Trends Analysis Report by Product (Oral, Nutrition Enteral Feeding Formulas,...
Cancer Cachexia Market
Cancer Cachexia Global Strategic Research Report 2024: Market to Reach $3.5 Billion by 2030, Driven by Promising Treatment Options
April 05, 2024 09:27 ET | Research and Markets
Dublin, April 05, 2024 (GLOBE NEWSWIRE) -- The "Cancer Cachexia - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.Global Cancer Cachexia Market to Reach...
Cancer Cachexia Market
Global Cancer Cachexia Market Worth $2.85 Billion by 2029: Combination Therapies Gaining Traction
March 20, 2024 11:13 ET | Research and Markets
Dublin, March 20, 2024 (GLOBE NEWSWIRE) -- The "Cancer Cachexia Market - Forecasts from 2024 to 2029" report has been added to ResearchAndMarkets.com's offering. This research report sheds light...
Actimed.png
Actimed Therapeutics Appoints Martin Walton as Chief Financial Officer
October 19, 2023 03:00 ET | Actimed Therapeutics
London, UK – 19th October 2023. Actimed Therapeutics Ltd (“Actimed”), a UK based clinical stage specialty pharmaceutical company focused on bringing innovation to the treatment of cancer cachexia and...
IGC Launches Phytoca
IGC Launches Phytocannabinoid Development Committee to Secure Preclinical Initiatives for IGC-501, IGC-502 and IGC-504
February 13, 2017 06:00 ET | India Globalization Capital
BETHESDA, Md., Feb. 13, 2017 (GLOBE NEWSWIRE) -- India Globalization Capital, Inc. (NYSE-MKT:IGC) announces today that its Phytocannabinoid Development Committee has started its review of...
IGC Provides Update
IGC Provides Update on Phytocannabinoid IP Portfolio
November 02, 2016 09:32 ET | India Globalization Capital
BETHESDA, Md., Nov. 02, 2016 (GLOBE NEWSWIRE) -- India Globalization Capital, Inc. (NYSE MKT:IGC) announces updates for five patents related to method and treatment of pain, seizures and eating...
IGC Announces Financ
IGC Announces Financial Results for Quarter Ended June 30, 2016
August 17, 2016 08:00 ET | India Globalization Capital
BETHESDA, Md., Aug. 17, 2016 (GLOBE NEWSWIRE) -- India Globalization Capital, Inc. (NYSE MKT:IGC) announces financial results for the quarter ended June 30, 2016. Total revenue was $288,493 for...
IGC Announces Financ
IGC Announces Financial Results for Fiscal Year Ended March 31, 2016
July 18, 2016 08:30 ET | India Globalization Capital
BETHESDA, Md., July 18, 2016 (GLOBE NEWSWIRE) -- India Globalization Capital, Inc. (NYSE MKT:IGC) announces financial results for the fiscal year ended March 31, 2016.  Total revenue was...